• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫内暴露于抗抑郁药物的儿童的神经发育。

Neurodevelopment of children exposed in utero to antidepressant drugs.

作者信息

Nulman I, Rovet J, Stewart D E, Wolpin J, Gardner H A, Theis J G, Kulin N, Koren G

机构信息

Motherisk Program, Hospital for Sick Children and University of Toronto, ON, Canada.

出版信息

N Engl J Med. 1997 Jan 23;336(4):258-62. doi: 10.1056/NEJM199701233360404.

DOI:10.1056/NEJM199701233360404
PMID:8995088
Abstract

BACKGROUND

Many women of reproductive age have depression, necessitating therapy with either a tricyclic antidepressant drug or a drug, such as fluoxetine, that inhibits the reuptake of serotonin. Whether these drugs affect fetal neurodevelopment is not known.

METHODS

We studied the children of 80 mothers who had received a tricyclic antidepressant drug during pregnancy, 55 children whose mothers had received fluoxetine during pregnancy, and 84 children whose mothers had not been exposed during pregnancy to any agent known to affect the fetus adversely. The children's global IQ and language development were assessed between 16 and 86 months of postnatal age by age-appropriate Bayley Scales of Infant Development or the McCarthy Scales of Children's Abilities (for IQ) and the Reynell Developmental Language Scales.

RESULTS

The mean (+/-SD) global IQ scores were 118+/-17 in the children of mothers who received a tricyclic antidepressant drug, 117+/-17 in those whose mothers received fluoxetine, and 115+/-14 in those in the control group. The language scores were similar in all three groups. The results were similar in children exposed to a tricyclic antidepressant drug or fluoxetine during the first trimester and those exposed throughout pregnancy. There were also no significant differences in temperament, mood, arousability, activity level, distractibility, or behavior problems in the three groups of children.

CONCLUSIONS

In utero exposure to either tricyclic antidepressant drugs or fluoxetine does not affect global IQ, language development, or behavioral development in preschool children.

摘要

背景

许多育龄女性患有抑郁症,需要使用三环类抗抑郁药或如氟西汀这类抑制5-羟色胺再摄取的药物进行治疗。这些药物是否会影响胎儿神经发育尚不清楚。

方法

我们研究了80名在孕期服用过三环类抗抑郁药的母亲的孩子、55名母亲在孕期服用过氟西汀的孩子,以及84名母亲在孕期未接触过任何已知会对胎儿产生不良影响药物的孩子。在出生后16至86个月,通过适合年龄的贝利婴儿发展量表或麦卡锡儿童能力量表(用于智商)以及雷内尔发育性语言量表对孩子的总体智商和语言发育进行评估。

结果

母亲服用三环类抗抑郁药的孩子的平均(±标准差)总体智商分数为118±17,母亲服用氟西汀的孩子为117±17,对照组孩子为115±14。三组孩子的语言分数相似。在孕早期接触三环类抗抑郁药或氟西汀的孩子与整个孕期都接触的孩子结果相似。三组孩子在气质、情绪、唤醒能力、活动水平、注意力分散度或行为问题方面也没有显著差异。

结论

子宫内接触三环类抗抑郁药或氟西汀不会影响学龄前儿童的总体智商、语言发育或行为发育。

相似文献

1
Neurodevelopment of children exposed in utero to antidepressant drugs.子宫内暴露于抗抑郁药物的儿童的神经发育。
N Engl J Med. 1997 Jan 23;336(4):258-62. doi: 10.1056/NEJM199701233360404.
2
Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study.孕期全程暴露于三环类抗抑郁药或氟西汀后的儿童发育:一项前瞻性对照研究。
Am J Psychiatry. 2002 Nov;159(11):1889-95. doi: 10.1176/appi.ajp.159.11.1889.
3
Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.母亲孕期暴露于文拉法辛、选择性 5-羟色胺再摄取抑制剂或未治疗的抑郁症后儿童的神经发育。
Am J Psychiatry. 2012 Nov;169(11):1165-74. doi: 10.1176/appi.ajp.2012.11111721.
4
Fluoxetine during pregnancy: impact on fetal development.孕期服用氟西汀:对胎儿发育的影响。
Reprod Fertil Dev. 2005;17(6):641-50. doi: 10.1071/rd05030.
5
Pharmacologic treatment of depression during pregnancy.孕期抑郁症的药物治疗。
JAMA. 1999 Oct 6;282(13):1264-9. doi: 10.1001/jama.282.13.1264.
6
Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy.孕期暴露或未暴露于抗抑郁药物的抑郁症母亲的子女随访。
J Pediatr. 2003 Apr;142(4):402-8. doi: 10.1067/mpd.2003.139.
7
Maternal fluoxetine treatment in the postpartum period: effects on platelet serotonin and plasma drug levels in breastfeeding mother-infant pairs.产后母亲使用氟西汀治疗:对母乳喂养母婴对中血小板血清素和血浆药物水平的影响。
Pediatrics. 2003 Nov;112(5):e425. doi: 10.1542/peds.112.5.e425.
8
Review of cardiovascular effects of fluoxetine, a selective serotonin reuptake inhibitor, compared to tricyclic antidepressants.
Curr Med Chem. 1998 Oct;5(5):381-90.
9
Mother-infant antidepressant concentrations, maternal depression, and perinatal events.产妇-婴儿抗抑郁药浓度、产妇抑郁与围产期事件。
J Clin Psychiatry. 2011 Jul;72(7):994-1001. doi: 10.4088/JCP.10m06461.
10
Long-term neurodevelopment of children exposed in utero to ciclosporin after maternal renal transplant.母亲肾移植后胎儿暴露于环孢素的儿童的长期神经发育。
Paediatr Drugs. 2010 Apr 1;12(2):113-22. doi: 10.2165/11316280-000000000-00000.

引用本文的文献

1
Prenatal exposure to psychotropics and analgesics on cognitive, linguistic and educational outcomes - a scoping review with focus on validity and reliability of outcome measures.产前暴露于精神药物和镇痛药对认知、语言及教育成果的影响——一项聚焦于成果测量有效性和可靠性的范围综述
BMC Pregnancy Childbirth. 2025 Mar 3;25(1):234. doi: 10.1186/s12884-025-07235-6.
2
Antidepressants use during pregnancy and child psychomotor, cognitive and language development at 2 years of age-Results from the 3D Cohort Study.孕期使用抗抑郁药与儿童2岁时的精神运动、认知和语言发育——三维队列研究结果
Front Pharmacol. 2023 Nov 16;14:1252251. doi: 10.3389/fphar.2023.1252251. eCollection 2023.
3
Psychiatric illness and pregnancy: A literature review.
精神疾病与妊娠:文献综述
Heliyon. 2023 Oct 20;9(11):e20958. doi: 10.1016/j.heliyon.2023.e20958. eCollection 2023 Nov.
4
Exposure to medication for neurological disease in pregnancy - time to consider the long-term implications?孕期接触治疗神经疾病的药物——是时候考虑其长期影响了吗?
EClinicalMedicine. 2023 Aug 24;63:102157. doi: 10.1016/j.eclinm.2023.102157. eCollection 2023 Sep.
5
Prenatal Selective Serotonin Reuptake Inhibitor Exposure, Depression, and Brain Morphology in Middle Childhood: Results From the ABCD Study.儿童中期的产前血清素再摄取抑制剂暴露、抑郁与脑形态:青少年大脑认知发展研究(ABCD研究)的结果
Biol Psychiatry Glob Open Sci. 2022 Feb 26;3(2):243-254. doi: 10.1016/j.bpsgos.2022.02.005. eCollection 2023 Apr.
6
Selective Serotonin Reuptake Inhibitor Pharmacokinetics During Pregnancy: Clinical and Research Implications.孕期选择性5-羟色胺再摄取抑制剂的药代动力学:临床及研究意义
Front Pharmacol. 2022 Feb 25;13:833217. doi: 10.3389/fphar.2022.833217. eCollection 2022.
7
Antidepressant Use During Pregnancy and the Potential Risks of Motor Outcomes and Intellectual Disabilities in Offspring: A Systematic Review.孕期使用抗抑郁药与后代运动结局和智力残疾的潜在风险:一项系统综述
Drugs Real World Outcomes. 2021 Jun;8(2):105-123. doi: 10.1007/s40801-021-00232-z. Epub 2021 Feb 12.
8
Maternal Gestational Weight Gain in Relation to Antidepressant Continuation in Pregnancy.母亲孕期体重增加与孕期继续使用抗抑郁药的关系。
Am J Perinatol. 2021 Nov;38(13):1442-1452. doi: 10.1055/s-0040-1713652. Epub 2020 Jun 30.
9
Psychotropic Treatment During Pregnancy: Research Synthesis and Clinical Care Principles.妊娠期精神药物治疗:研究综合与临床护理原则。
J Womens Health (Larchmt). 2020 Mar;29(3):310-318. doi: 10.1089/jwh.2019.7781. Epub 2019 Dec 3.
10
Use of Prescribed Psychotropics during Pregnancy: A Systematic Review of Pregnancy, Neonatal, and Childhood Outcomes.孕期使用处方精神药物:对妊娠、新生儿及儿童期结局的系统评价
Brain Sci. 2019 Sep 14;9(9):235. doi: 10.3390/brainsci9090235.